Search results for "microbiome"

showing 10 items of 395 documents

Gut bacterial ClpB-like gene function is associated with decreased body weight and a characteristic microbiota profile

2020

[Background]: The chaperone ClpB, a bacterial protein, is a conformational antigen-mimetic of α-melanocyte-stimulating hormone (α-MSH) implicated in body weight regulation in mice. We here investigated the potential associations of gut bacterial ClpB-like gene function with obesity status and gut microbiota in humans.

MaleRikenellaceaeGut floraPrevotellaceaemedicine.disease_causeFecesMice0302 clinical medicineOverweight personsClostridiaceae2. Zero hunger0303 health sciencesIntestins -- MalaltiesEndopeptidase ClpFecal Microbiota TransplantationMiddle AgedPersones obeses3. Good healthIntestins -- Microbiologialcsh:QR100-130FemaleIntestines -- DiseasesAdultMicrobiology (medical)medicine.medical_specialtyFirmicutesBiologyIntestines -- Microbiologydigestive systemMicrobiologylcsh:Microbial ecology03 medical and health sciencesInternal medicinemedicineAnimalsHumansMicrobiomeObesityBacterial gene functionEscherichia coliAged030304 developmental biologyBacteriaResearchBacterial gene function ; Body weight regulation ; Microbiome ; Obesitybiology.organism_classificationGastrointestinal MicrobiomeMice Inbred C57BLCross-Sectional StudiesEndocrinologyCase-Control StudiesBody weight regulationMicrobiomeCLPB030217 neurology & neurosurgery
researchProduct

Compensatory IgM to the Rescue: Patients with Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No Changes in Oral Microb…

2021

Abstract IgA is the most abundant Ab in the human body. However, most patients with selective IgA deficiency (SIgAD) are asymptomatic. IgM, and to lesser extent IgG Abs, are generally presumed to compensate for the lack of IgA in SIgAD by multiplying and adopting functions of IgA. We used data from the Northern Finland Birth Cohort 1966 to investigate whether SIgAD patients have differences in levels of natural Abs to oxidized epitopes compared with 20 randomly selected healthy controls. First, we screened the saliva and serum samples from the Northern Finland Birth Cohort 1966 cohort (n = 1610) for IgA concentration. We detected five IgA-deficient subjects, yielding a prevalence of 0.3%, w…

MaleSalivaImmunologySelective IgA deficiencyGut floraAsymptomaticEpitopesuuimmunologiaMalondialdehydeRNA Ribosomal 16SmedicineImmunology and AllergyHumanslimakalvotSalivaFinlandimmuunivajausoireyhtymätbiologyBacteriabusiness.industryvasta-aineetIgA DeficiencyGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationGastrointestinal MicrobiomeImmunoglobulin ALipoproteins LDLmikrobistoImmunoglobulin MCase-Control StudiesImmunoglobulin GImmunologyCohortBirth CohortFemale3111 Biomedicinemedicine.symptombusinessDysbiosisLipoproteinImmunoHorizons
researchProduct

Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor–mediated Dysbiosis

2020

Background & Aims Wheat has become the world's major staple and its consumption correlates with prevalence of noncommunicable disorders such as inflammatory bowel diseases. Amylase trypsin inhibitors (ATIs), a component of wheat, activate the intestine's innate immune response via toll-like receptor 4 (TLR4). We investigated the effects of wheat and ATIs on severity of colitis and fecal microbiota in mice. Methods C57BL/6 wild-type and Tlr4–/– mice were fed wheat- or ATI-containing diets or a wheat-free (control) diet and then given dextran sodium sulfate to induce colitis; we also studied Il10–/– mice, which develop spontaneous colitis. Changes in fecal bacteria were assessed by taxa-speci…

MaleTrypsin inhibitorPlant Proteins DietarySeverity of Illness IndexInflammatory bowel diseaseMicrobiologyFecesMicemedicineAnimalsHumansAmylaseColitisTriticumFecesMice KnockoutHepatologybiologyDextran SulfateGastroenterologyfood and beveragesFecal Microbiota TransplantationColitisInflammatory Bowel Diseasesmedicine.diseaseAnimal FeedImmunity InnateGastrointestinal MicrobiomeToll-Like Receptor 4TransplantationDisease Models Animalbiology.proteinTLR4DysbiosisTrypsin InhibitorsDysbiosisSignal TransductionGastroenterology
researchProduct

Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients: A Population-Based Study.

2022

(1) Background: A clinical laboratory index to assess gut dysbiosis is the F/B ratio < 0.8. In fact, an elevated proportion of Firmicutes and a reduced population of Bacteroides in diabetes type 2 (T2D) subjects has been observed. This study aimed to detail the dysbiosis status in the Italian population, focusing on some pathogenic spectra (T2D) or metabolic disorders. (2) Material and methods: A quantity of 334 fecal samples was analyzed in order to perform genetic testing and sequencing. (3) Results: A trend in over imbalance was observed in the percentage of Proteobacteria (median value: 6.75%; interquartile range (IQR): 3.57–17.29%). A statistically significant association (&ch…

MalediabetesHealth Toxicology and MutagenesisSettore BIO/12dysbiosicandidiasiPublic Health Environmental and Occupational HealthFirmicutesmicrobiota.candidiasisGastrointestinal MicrobiomeFecesDiabetes Mellitus Type 2diabeteProteobacteriamicrobiotadysbiosis; microbiota; diabetes; candidiasisHumansDysbiosisBacteroidesFemaleInternational journal of environmental research and public health
researchProduct

Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics

2020

Human milk is the sole and recommended nutrition for the newborn infant and contains one of the largest constituents of diverse oligosaccharides, dubbed human milk oligosaccharides (HMOs). Preclinical and clinical association studies indicate that HMOs have multiple physiological functions largely mediated through the establishment of the gut microbiome. Until recently, HMOs were not available to investigate their role in randomized controlled intervention trials. To our knowledge, this is the first report on the effects of 2 HMOs on establishing microbiota in newborn infants. We provide a detailed description of the microbiota changes observed upon feeding a formula with 2 HMOs in comparis…

Malefecal community types030309 nutrition & dieteticsmedicine.drug_classLNnTAntibioticsPhysiologyOligosaccharidesGut floraformulaMicrobiologyantibioticsHost-Microbe Biology03 medical and health sciencesFecesfluids and secretionsDouble-Blind MethodVirologyRNA Ribosomal 16SmicrobiotaMedicineHumansFeceshealth care economics and organizations030304 developmental biologyBifidobacterium0303 health sciencesbiologyBacteriaMilk Humanbusiness.industryInfant Newbornbiology.organism_classificationinfantInfant Formula2′FLQR1-502Anti-Bacterial AgentsGastrointestinal MicrobiomeClinical trialBifidobacteriaceaeBreast FeedingInfant formulaEnterotypeFemalehuman milk oligosaccharidesBifidobacteriumbusinessResearch ArticlemBio
researchProduct

Helicobacter pylori and some aspects of gut microbiota in children

2018

Helicobacter pylori infection in children differs from infection in adults in many aspects. The rate of infection, epidemiology, clinical presentations and complications, the applicability of diagnostic tests, antibiotic resistance, treatment options, and success rates differ significantly. Due to all these differences, management guidelines for children and adults differ also substantially. In 2017, the Updated ESPGHAN and NASPGHAN Guidelines on the management of H. pylori infection in children were published, emphasizing the differences in clinical presentation and indications for treatment, stating that the primary goal of clinical investigation in children is to identify the cause of up…

Malemedicine.medical_specialtyLongitudinal studyAllergyGut floraHelicobacter InfectionsAtopy03 medical and health sciences0302 clinical medicineAntibiotic resistanceInternal medicineEpidemiologymedicineHumans030212 general & internal medicineHelicobacter pyloribiologybusiness.industryIncidence (epidemiology)GastroenterologyGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsGastrointestinal MicrobiomeTreatment OutcomeInfectious DiseasesFemale030211 gastroenterology & hepatologybusinessHelicobacter
researchProduct

Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure

2019

Background: Recent evidence endorses gut microbiota dysregulation in the pathophysiology of heart failure (HF). Small intestinal bacterial overgrowth (SIBO) might be present in HF and associated with poor clinical outcomes. Lactulose breath testing is a simple noninvasive test that has been advocated as a reliable indicator of SIBO. In patients with HF, we aimed to evaluate the association with clinical outcomes of the exhaled hydrogen (H-2) and methane (CH4) concentrations through the lactulose breath test. Methods and Results: We included 102 patients with HF in which lactulose SIBO breath tests were assessed. Cumulative gas was quantified by the area under the receiver operating characte…

Malemedicine.medical_specialtyheart failuresmall intestinal bacterial overgrowth030204 cardiovascular system & hematologyRate ratioGastroenterologyArticle03 medical and health sciencesLactulose0302 clinical medicineInterquartile rangeInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansGutProspective Studies030212 general & internal medicineAgedAged 80 and overHeart FailureBreath testBacteriamedicine.diagnostic_testReceiver operating characteristicbusiness.industryHazard ratiomedicine.diseaseGastrointestinal MicrobiomeHospitalizationBreath TestsExhalationHeart failureFemalebreath testsprognosisCardiology and Cardiovascular MedicinebusinessMethaneFollow-Up StudiesHydrogenmedicine.drug
researchProduct

Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity

2013

The microbiomes in the gastrointestinal tract (GIT) of individuals receiving antibiotics and those in obese subjects undergo compositional shifts, the metabolic effects and linkages of which are not clearly understood. Herein, we set to gain insight into these effects, particularly with regard to carbohydrate metabolism, and to contribute to unravel the underlying mechanisms and consequences for health conditions. We measured the activity level of GIT carbohydrate-active enzymes toward 23 distinct sugars in adults patients (n = 2) receiving 14-d β-lactam therapy and in obese (n = 7) and lean (n = 5) adolescents. We observed that both 14 d antibiotic-treated and obese subjects showed higher …

MaleobesityAnabolismAntibioticsBody Mass Indexmetabolic reconstructionantibiotic therapySystems and Synthetic Biology2. Zero hungerSysteem en Synthetische Biologie0303 health sciencesGastrointestinal tractMicrobiotaHuman gastrointestinal tractGastroenterologyBiotaAnti-Bacterial Agents3. Good healthInfectious Diseasesmedicine.anatomical_structureglycosidaseCarbohydrate MetabolismFemaleResearch PaperAdultMicrobiology (medical)medicine.medical_specialtyAdolescentmedicine.drug_classCarbohydrate metabolismBiologyMicrobiology03 medical and health sciencesInsulin resistanceInternal medicinemedicineHumansMicrobiomeObesityVLAGAged030304 developmental biologyMetabolic reconstruction030306 microbiologyAntibiotic therapymedicine.diseaseObesityGlycosidaseGastrointestinal TractDistal gutEndocrinologyHyperglycemiaInsulin Resistancedistal gut
researchProduct

Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats

2020

Understanding the importance of the gut microbiota (GM) in non-alcoholic fatty liver disease (NAFLD) has raised the hope for therapeutic microbes. We have shown that high hepatic fat content associated with low abundance of Faecalibacterium prausnitzii in humans and, further, the administration of F. prausnitzii prevented NAFLD in mice. Here, we aimed at targeting F. prausnitzii by prebiotic xylo-oligosaccharides (XOS) to treat NAFLD. First, the effect of XOS on F. prausnitzii growth was assessed in vitro. Then, XOS was supplemented or not with high (HFD, 60% of energy from fat) or low (LFD) fat diet for 12 weeks in Wistar rats (n = 10/group). XOS increased F. prausnitzii growth, having onl…

MalesuolistomikrobistoPROGRESSIONBIFIDOBACTERIASTEATOHEPATITISNon-alcoholic Fatty Liver DiseaseCecumDiet Fat-RestrictedaineenvaihduntaFatty Acidsrasvamaksafood and beveragesmitochondriaLiverprebioticBody CompositionBIOPSIESFemaleOxidation-Reductionlcsh:Nutrition. Foods and food supplymitokondriotGlucuronateslcsh:TX341-641Diet High-Fatdigestive systemArticleDYSBIOSISprebiootitINFLAMMATIONLIVER-DISEASEINTESTINAL MICROBIOTAoligosaccharidesoligosakkariditAnimalsRats WistarTriglyceridesfatty livergut microbiotaFaecalibacterium prausnitziinutritional and metabolic diseasesLipid MetabolismGastrointestinal MicrobiomeRatsFAECALIBACTERIUM-PRAUSNITZIIGlucosePrebiotics416 Food Scienceaineenvaihduntatuotteet3111 BiomedicineEnergy IntakeEnergy MetabolismmetabolismNutrients
researchProduct

High frequencies of antibiotic resistance genes in infants' meconium and early fecal samples

2016

The gastrointestinal tract (GIT) microbiota has been identified as an important reservoir of antibiotic resistance genes (ARGs) that can be horizontally transferred to pathogenic species. Maternal GIT microbes can be transmitted to the offspring, and recent work indicates that such transfer starts before birth. We have used culture-independent genetic screenings to explore whether ARGs are already present in the meconium accumulated in the GIT during fetal life and in feces of 1-week-old infants. We have analyzed resistance to β-lactam antibiotics (BLr) and tetracycline (Tcr), screening for a variety of genes conferring each. To evaluate whether ARGs could have been inherited by maternal tr…

Meconium0301 basic medicineantibiotic resistancemedicine.drug_classAntibioticsmeconiumMedicine (miscellaneous)Biologybeta-Lactam ResistanceMicrobiologyCohort Studies03 medical and health sciencesAntibiotic resistancefluids and secretionsMeconiumPregnancymedicineHumansmecAFecestetracyclinePregnancyMaternal Transmissiongastrointestinal microbiotaSCCmecInfant NewbornTetracycline ResistanceInfantmedicine.diseaseGastrointestinal Microbiome030104 developmental biologyImmunologyColostrumFemale
researchProduct